2 results
Approved WMOPending
Primary: To demonstrate the superior efficacy of Nasalfent in the treatment of BTCP in opioid tolerant subjects who are receiving regular opioid therapy.Secondary: To demonstrate the safety, tolerability, and acceptability of Nasalfent in the…
Approved WMOCompleted
The primary objective of the study is to demonstrate the effectiveness of the computer algorithm (LOGIC-Insulin) against the standard routine protocol for the normalisation of blood glucose concentrations in the ICU.The secondary objective of the…